NCT00081744View on ClinicalTrials.gov

Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

850

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions

Gram-Positive Bacterial InfectionsCross Infection

Interventions

DRUG

Tigecycline

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00081744 - Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects | Biotech Hunter | Biotech Hunter